THE HYPOTHESES OF DIFFERENT DOPAMINE RECEPTOR MECHANISMSCOSTALL B; NAYLOR RJ.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 3; PP. 215-229; BIBL. 112 REF.Article

INTERACTION OF THE PUTATIVE DOPAMINE AUTORECEPTOR AGONISTS 3-PPP AND TL-99 WITH (³H) APOMORPHINE BINDING SITES IN RAT STRIATAL MEMBRANESWILLIAMS M; TOTARO JA.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 86; NO 1; PP. 35-42; BIBL. 31 REF.Article

DOPAMINE RECEPTOR PROFILE OF CO-DERGOCRINE (HYDERGINEREG.) AND ITS COMPONETSMARKSTEIN R.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 86; NO 2; PP. 145-155; BIBL. 20 REF.Article

EVIDENCE FOR THE PRESENCE OF D₂ AND 5-HT₂ RECEPTORS IN THE HUMAN PREFONTAL CORTEXMITA T; KUNO T; NAKAI H et al.1982; JAPANESE JOURNAL OF PHARMACOLOGY; ISSN 0021-5198; JPN; DA. 1982; VOL. 32; NO 6; PP. 1027-1032; BIBL. 24 REF.Article

DECREASED PERIPHERAL DOPAMINERGIC ACTIVITY IN ESSENTIAL HYPERTENSION.KJELDSEN SE; FLAATEN B; EIDE I et al.1983; SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION; ISSN 0036-5513; NOR; DA. 1983; VOL. 43; NO 1; PP. 15-20; BIBL. 25 REF.Article

ABNORMAL INVOLUNTARY MOVEMENTS: A STUDY OF DOPAMINERGIC RECEPTOR INTERACTIONAGNOLI A; RUGGIERI S; DEL ROSCIO S et al.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 305-312; BIBL. 8 REF.Article

INTERACTION OF ALLOPURINOL WITH HUMAN BLOODTHOMAS G; FELDMAN S; KRAMER WG et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 10; PP. 1937-1940; BIBL. 18 REF.Article

POLYMORPHIE UND TRACHTAENDERUNG VON PROPYPHENAZON = POLYMORPHISME ET DISSOLUTION DE LA PROPYPHENAZONEMUELLER BW; BEER Y.1982; ACTA PHARMACEUTICA TECHNOLOGICA; ISSN 0340-3157; DEU; DA. 1982; VOL. 28; NO 2; PP. 97-102; ABS. ENG; BIBL. 8 REF.Article

THE COMPETITIVE INHIBITION OF GLUCOSE TRANSPORT IN HUMAN ERYTHROCYTES BY COMPOUNDS OF DIFFERENT STRUCTURESLACKO L; WITTKE B.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 10; PP. 1925-1929; BIBL. 11 REF.Article

IN VITRO-FREISETZUNG VON NICOTINSAEUREBENZYLESTER AUS VERSCHIEDENEN LOESUNGSSALBEN = LIBERATION IN VITRO DE NICOTINIQUE ACIDE BENZYLESTER A PARTIR DE DIVERS VEHICULESLIPPOLD BC; TEUBNER A.1982; ACTA PHARMACEUTICA TECHNOLOGICA; ISSN 0340-3157; DEU; DA. 1982; VOL. 28; NO 2; PP. 115-125; ABS. ENG; BIBL. 26 REF.Article

DIFFERENTIAL BLOCKING EFFECTS OF SEVERAL DOPAMINE RECEPTOR ANTAGONISTS FOR PERIPHERAL PRE- AND POSTSYNAPTIC DOPAMINE RECEPTORS IN THE ANESTHETIZED DOGSHEPPERSON NB; DUVAL N; MASSINGHAM R et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 221; NO 3; PP. 753-761; BIBL. 27 REF.Article

DOPAMINERGIC MECHAISMS IN THIOPHENE-2-ALDOXIME TREMORKURKJIAN R; BANNA NR.1982; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1982; VOL. 38; NO 7; PP. 841-842; BIBL. 6 REF.Article

ACTIVATION BY REDUCED GLUTATHIONE OF METHOTREXATE TRANSPORT INTO ISOLATED RAT LIVER CELLSLESZCYNSKA A; PFAFF E.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 10; PP. 1911-1918; BIBL. 23 REF.Article

POSSIBLE DA AGONIST PROPERTIES OF NALOXONEFEIGENBAUM J; YANAI J; BLASS R et al.1982; INTERNATIONAL JOURNAL OF NEUROSCIENCE; ISSN 0020-7454; GBR; DA. 1982; VOL. 17; NO 3; PP. 139-144; BIBL. 2 P.Article

BRAIN DOPAMINE RECEPTORSSEEMAN P.1980; PHARMACOL. REV.; ISSN 0031-6997; USA; DA. 1980; VOL. 32; NO 3; 58 P.; BIBL. 1278 REF.Serial Issue

CHARACTERIZATION OF NORMAL AND SUPERSENSITIVE DOPAMINE RECEPTORS: EFFECTS OF ERGOT DRUGS AND NEUROPEPTIDESFUXE K; AGNATI LF; KOHLER C et al.1981; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1981; VOL. 51; NO 1-2; PP. 3-37; BIBL. 3 P.Article

APOMORPHINE HYPOTHERMIA: AN INDEX OF CENTRAL DOPAMINE RECEPTOR FUNCTION IN MANCUTLER NR; POST RM; BUNNEY WE JR et al.1979; COMMUNIC. PSYCHOPHARMACOL.; GBR; DA. 1979 PUBL. 1980; VOL. 3; NO 5; PP. 375-382; BIBL. 23 REF.Article

SYMPOSIUM ON RECEPTORS OF DOPAMINE ANTAGONISTS: NEW BIOCHEMICAL APPROACHES.LEYSEN J; LADURON P.1978; LIFE SCI.; GBR; DA. 1978; VOL. 23; NO 6; PP. 537-538Article

EVIDENCE FOR DOPAMINE RECEPTORS IN THE HUMAN BRAIN MEDIATING SEDATION AND SLEEP.CORSINI GU; DEL ZOMPO M; MANCONI S et al.1977; LIFE SCI.; G.B.; DA. 1977; VOL. 20; NO 9; PP. 1613-1618; BIBL. 17 REF.Article

PERIPHERAL CARDIOVASCULAR DOPAMINE RECEPTORS.PENDLETON RG; SETLER PE.1977; GEN. PHARMACOL.; G.B.; DA. 1977; VOL. 8; NO 1; PP. 1-5; BIBL. 23 REF.Article

STRIATAL BINDING OF 2-AMINO-6,7-(³H) DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE TO TWO DOPAMINERGIC SITES DISTINGUISHED BY THEIR LOW AND HIGH AFFINITY FOR NEUROLEPTICSLIST SJ; WREGGETT KA; SEEMAN P et al.1982; J. NEUROSCI.; ISSN 0270-6474; USA; DA. 1982; VOL. 2; NO 7; PP. 895-906; BIBL. 2 P.Article

EFFECT OF APOMORPHINE ON SCHIZOPHRENIC SYMPTOMS.SMITH RC; TAMMINGA C; DAVIS JM et al.1977; J. NEUR. TRANSM.; AUSTR.; DA. 1977; VOL. 40; NO 2; PP. 171-176; BIBL. 16 REF.Article

DOPAMINE RECEPTORS IN THE CENTRAL NERVOUS SYSTEMCREESE I; MORROW AL; LEFF SE et al.1982; INT. REV. NEUROBIOL.; ISSN 0074-7742; USA; DA. 1982; VOL. 23; PP. 255-301; BIBL. 6 P.Article

PERIPHERAL DOPAMINERGIC RECEPTORSIMBS JL ED; SCHWARTZ J ED.1979; ADV. IN THE BIOSCI.; DEU; DA. 1979; VOL. 20; XI-405 P.; BIBL. DISSEM.Conference Paper

DOPAMIENERGE NEUROTRANSMISSION BEIM PARKINSON-SYNDROM. = NEUROTRANSMISSION DOPAMINERGIQUE DANS LA MALADIE DE PARKINSONLAMPRECHT F.1977; FORTSCHR. NEUROL. PSYCHIATR. GRENZGEB.; DTSCH.; DA. 1977; VOL. 45; NO 8; PP. 459-471; ABS. ANGL.; BIBL. 1 P. 1/2Article